Cure Parkinson’s welcomes five new trustees
Cure Parkinson’s has grown rapidly in recent years, influencing and funding increasingly larger projects with the goal of moving the research forward faster than ever.
As part of our growth it’s important to expand our board of trustees, to add new expertise and fresh perspective, and to that end we are delighted to welcome five new trustees to the charity: Alison Anderson, a long-term Cure Parkinson’s fundraiser who was diagnosed with Parkinson’s in 2015 and has taken on some incredible cycle challenges for the charity; Helen Fitzgerald, who has 20 years’ experience in the financial sector and feels deeply connected to the cause as her partner lives with the condition; Phill Robinson, a leading entrepreneur in the software industry and member of the Cure Parkinson’s Development Board who was diagnosed with Parkinson’s in 2017; Linda Feighery, an expert in medical communications with UCB Pharma, and Mike Ashton, an experienced trustee with a wealth of experience in marketing and brand management.
We have worked to understand the different skills that might be helpful to the board as the charity has continued to grow, and we have been humbled by the strong response from a wide range of experts who wanted to join our mission. It is also very important to Cure Parkinson’s that our board includes people living with Parkinson’s, as well as experts in relevant fields, and we are always especially pleased to find those experts within the Parkinson’s community whether they are living with the condition or affected by it.
Each of our new trustees brings with them a wealth of experience in their respective areas of expertise, which will undoubtedly add to the board’s broad, existing range of skillsets and help us to continue to grow as a charity.
